Drug Trial Radar · NCT05827016
A Study to Compare Iberdomide Maintenance Versus Lenalidomide Maintenance Therapy Following Autologous Stem Cell Transplant in Participants With Newly Diagnosed Multiple Myeloma
Last checked: Nov 20, 2026Latest source record: Sep 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
1,230
Actual
Start
Jun 22, 2023
Primary completion
Mar 15, 2029
Study completion Jan 1, 2036
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Apr 24, 2023
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to compare the effectiveness of iberdomide maintenance to lenalidomide maintenance therapy after autologous stem cell transplantation (ASCT) in participants with newly diagnosed multiple myeloma (NDMM).
Conditions
- Multiple Myeloma
Interventions
IberdomideDrug
Specified dose on specified days
LenalidomideDrug
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Progression-free survival (PFS)Time frame: Up to 6 years
Locations
269 sites in 34 countries. Site status is shown where the registry gives one.
Local Institution - 0202
Aurora, Colorado
Local Institution - 0007
Jacksonville, Florida
Local Institution - 0308
Tampa, Florida
Local Institution - 0192
Tampa, Florida
Local Institution - 0003
Weston, Florida
Local Institution - 0019
Athens, Georgia
Local Institution - 0018
Atlanta, Georgia
Local Institution - 0021
Augusta, Georgia
Local Institution - 0237
Chicago, Illinois
University of Kansas Cancer Center - The Richard and Annette Bloch Cancer Care Pavilion
Westwood, Kansas
Local Institution - 0205
Clinton, Maryland
Local Institution - 0279
Worcester, Massachusetts
Local Institution - 0001
Ann Arbor, Michigan
Local Institution - 0257
Detroit, Michigan
Local Institution - 0296
Grand Rapids, Michigan
Local Institution - 0303
Rochester, Minnesota
Local Institution - 0207
Hattiesburg, Mississippi
Local Institution - 0191
Morristown, New Jersey
Local Institution - 0328
Brooklyn, New York
Local Institution - 0288
Mineola, New York
Local Institution - 0180
New York, New York
Local Institution - 0020
New York, New York
Local Institution - 0274
Westbury, New York
Local Institution - 0331
Charlotte, North Carolina
Local Institution - 0005
Charlotte, North Carolina
Local Institution - 0281
Durham, North Carolina
Local Institution - 0286
Winston-Salem, North Carolina
Local Institution - 0322
Winston-Salem, North Carolina
Local Institution - 0238
Cincinnati, Ohio
Local Institution - 0299
Cleveland, Ohio
Local Institution - 0002
Cleveland, Ohio
Local Institution - 0017
Kansas, Ohio
Local Institution - 0301
Mayfield Heights, Ohio
Local Institution - 0013
Toledo, Ohio
Local Institution - 0300
Wooster, Ohio
Local Institution - 0203
Eugene, Oregon
Local Institution - 0012
Philadelphia, Pennsylvania
Local Institution - 0011
Philadelphia, Pennsylvania
Local Institution - 0253
Pittsburgh, Pennsylvania
Local Institution - 0294
Germantown, Tennessee
Showing 40 of 269 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.